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Background: Sulfotransferases with distinct specificities act in sequence in the heparan sulfate biosynthetic pathway.
Results: The crystal structure of 2-O-sulfotransferase with bound substrate reveals its requirements for substrate recognition.
Conclusion: The 2-O-sulfotransferase recognizes N-sulfate but excludes 6-O-sulfate on substrates.
Significance: The results advance the understanding of cellular control for the biosynthesis of heparan sulfate.
Heparan sulfate (HS) is an abundant polysaccharide in the
animal kingdom with essential physiological functions. HS is
composed of sulfated saccharides that are biosynthesized
through a complex pathway involving multiple enzymes. In vivo
regulation of this process remains unclear. HS 2-O-sulfotrans-
ferase (2OST) is a key enzyme in this pathway. Here, we report
the crystal structure of the ternary complex of 2OST, 3-phos-
phoadenosine 5-phosphate, and a heptasaccharide substrate.
Utilizing site-directed mutagenesis and specific oligosaccharide
substrate sequences, we probed the molecular basis of specific-
ity and 2OST position in the ordered HS biosynthesis pathway.
These studies revealed that Arg-80, Lys-350, and Arg-190 of
2OST interact with the N-sulfo groups near the modification
site, consistent with the dependence of 2OST on N-sulfation. In
contrast, 6-O-sulfo groups on HS are likely excluded by steric
and electrostatic repulsion within the active site supporting the
hypothesis that 2-O-sulfation occurs prior to 6-O-sulfation. Our
results provide the structural evidence for understanding the
sequence of enzymatic events in this pathway.
Heparan sulfate (HS)3 is a highly sulfated polysaccharide that
is widely present on the mammalian cell surfaces and in the
extracellular matrix. HS participates in a wide range of physio-
logical and pathophysiological functions, including embryonic
development, inflammatory responses, blood coagulation, and
assisting in viral/bacterial infections (1). HS consists of a disac-
charide repeating unit with glucosamine and either glucuronic
acid (GlcA) or iduronic acid (IdoA), each of which is capable of
carrying sulfo groups. The position of the sulfo groups and the
distributions of IdoA and GlcA units dictate the function of HS
(2). A specialized biosynthetic pathway, involving multiple HS
sulfotransferases and an epimerase, is required for the prepara-
tion of functional HS with elaborate sulfation patterns (3). The
heparan sulfate 2-O-sulfotransferase (2OST) is a key enzyme in
the HS biosynthetic pathway.
2OST is responsible for the transfers of a sulfo group to the
2-OH position of preferentially IdoA, and to a limited extent
GlcA, within HS polysaccharides to form 2-O-sulfated iduronic
acid (IdoA2S) or 2-O-sulfated glucuronic acid (GlcA2S). The
IdoA2S unit is a common structural motif found in cellular HS
and is required for binding several growth factors and is essen-
tial for triggering growth factor-mediated signal transduction
pathways (4, 5). The critical physiological functions of IdoA2S
residues have been revealed through numerous studies. For
example, the 2OST-knock-out mice exhibit renal agenesis and
die in the neonatal period. These animals also display retarda-
tion of eye development and skeletal over mineralization, dem-
onstrating the essential role of 2OST in regulating embryonic
development (6). Furthermore, decreased expression of 2OST
leads to the reduction of neutrophil infiltration during acute
inflammation in mice, implicating the function of IdoA2S motif
in inflammatory responses (7). In Caenorhabditis elegans,
2OST has been implicated in axon migration/guidance and
nervous system development (8, 9). Dependence on 2-O-sulfa-
tion is notably less critical in Drosophila. The 2OST/ Dro-
sophila meanogaster synthesizes HS with higher levels of 6-O-
sulfation, which may compensate for the loss of 2-O-sulfation
(10).
Understanding the biosynthesis of HS plays a significant role
in developing a new generation of heparin, a commonly used
anticoagulant drug (11). Heparin is a HS-like polysaccharide
that is isolated from porcine intestine or bovine lung through a
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poorly regulated supply chain. The worldwide distribution of
contaminated heparin in 2007 raised the concerns over the
safety and reliability of animal-sourced heparins (12). A cost-
effective method for producing pharmaceutical grade synthetic
heparin is highly desirable. A chemoenzymatic approach to
synthesize heparin and HS oligosaccharides is becoming a very
promising approach to accomplish this goal (13–16). The new
method has dramatically improved the synthesis efficiency and
product purity. HS is also being investigated for possible use in
the treatment of inflammation-related diseases and cancer (17).
Better understanding of the enzymes used in the chemoenzy-
matic approach should aid in the production of heparin-based
therapeutics tailored for specific disease targets.
The cellular mechanism regulating HS biosynthesis is largely
unknown. Understanding the substrate specificities and mech-
anisms of HS biosynthetic enzymes is crucial for dissecting this
fundamental process. In this article, we report a crystal struc-
ture of a ternary complex of 2OST with 3-phosphoadenosine
5-phosphate (PAP) and a heptasaccharide acceptor substrate.
Numerous critical interactions between the enzyme and the
heptasaccharide were identified, providing structural evidence
for the substrate specificity of this enzyme. A series of structur-
ally defined oligosaccharides were synthesized to examine the
contribution of oligosaccharide size and functional groups to
2OST modification. Our results suggest that 2OST utilizes
multiple structural elements to distinguish sulfation patterns of
the substrate, controlling the order and extent of the 2-O-sul-
fation in the HS biosynthetic process.
EXPERIMENTAL PROCEDURES
Crystallization and Data Collection—Maltose-binding pro-
tein (MBP)-2OST was expressed and purified as described pre-
viously (18). Crystals of MBP-2OST were grown using the
vapor diffusion sitting drop method by mixing 400 nl of MBP-
2OST at 20 mg/ml in 25 mM Tris, pH 7.5, 75 mM NaCl, 5 mM
maltose, 1 mM DTT, 4 mM PAP, and 10 mM heptasaccharide
with 400 nl of the reservoir solution consisting of 17.9% PEG
4000, 60 mM sodium citrate, pH 5.6, 120 mM ammonium ace-
tate, 10.5% glycerol, and 10 mM hexamine cobalt chloride. Prior
to mounting the reservoir solution was switched to 25.5% PEG
4000, 15% glycerol, 85 mM sodium citrate, and 170 mM ammo-
nium acetate. After 5.5 h of equilibration the crystal was har-
vested and frozen directly into liquid nitrogen. Data were col-
lected to 3.45 Å on the SER-CAT bending magnet beamline at
APS with a wavelength of 1 Å. Molecular replacement was car-
ried out in PHENIX using the 2OST biological trimer and the
individual MBP coordinates from Protein Data Bank ID code
3F5F as the search models (18, 19). The model was refined using
multiple cycles of manual model building in Coot followed by
refinement in PHENIX using minimization, individual ADP
B-factor refinement, and torsion angle simulated annealing
(Table 1) (19, 20). TLS (Translation/Libration/Screw) refine-
ment was also used in later rounds of refinement. Noncrystal-
lographic symmetry restraints were utilized between the 2OST
molecules, saccharides E and F of the heptasaccharides bound
and between the MBP molecules excluding loops that had dif-
ferent conformations in the density. The final model consisted
of two trimers of the MBP-2OST fusion monomers labeled
A–F. There is electron density for all six 2OST molecules, with
each containing PAP. All monomers but monomer C contain
density for the heptasaccharide substrate. There is strong den-
sity for three monomers of MBP with weak density for mole-
cules B and F and no density for molecule A. The model was
refined to a Rwork of 17.9% and Rfree 22.4% (Protein Data Bank
ID code 4NDZ). The quality of the structure was analyzed with
MolProbity (Table 1) (21).
2-O-Sulfation Assay—Oligosaccharides (0.05 mg/ml) were
incubated at 37 °C for 2 h with 2OST (0.2 mg/ml) and 35S-PAPS
in 200 l of MES buffer system. The reaction mixture was ana-
lyzed using a silica-based polyamine HPLC column. Determi-
nations were carried out in duplicate.
Disaccharide Analysis—To determine the size of the 35S sul-
fation, the sample was subjected to nitrous acid degradation at
pH 1.5 to produce 35S-labeled disaccharide as described by
Shively and Conrad (22). The resultant 35S-labeled disaccha-
rides were resolved using a C18 reverse-phase column (0.46 
25 cm; Vydac) under reverse-phase ion-pairing HPLC condi-
tions (23). The identities of the disaccharides were determined
by co-elution with the appropriate 35S-labeled disaccharide
standards.
Quantum Mechanics and Molecular Dynamics Calculations—
Gaussian optimization calculations were carried out for the tri-
saccharide unit, GlcNS-IdoA-GlcNS, with the central IdoA unit
in the 4C1, 1C4, and 2S0 conformations, as well as replaced by a
GlcA in the 4C1 conformation. All optimizations were done at
the B97-XD level with the 6-31g(d,p) basis set. We also
included the polarization continuum model with water as the




Unit cell a  155.72 Å, b  170.69 Å,
c  183.96 Å;       90°
Space group P212121
Resolution (Å) 50.0-3.45
No. of observations 386,263
Unique reflections 64,322
Rsym (%) (last shell)a 10.7 (63.8)
I/I (last shell) 8.8 (2.3)
Mosaicity range 0.39–0.56




Overall Wilson B value (Å) 94.3





Root mean square deviation
from ideal values
Bond length (Å) 0.005
Bond angle (°) 0.84
Dihedral angle (°) 11.2
Ramachandran statisticsd
Favored regions (98%) 95.0
Allowed regions (99.8%) 99.5
a Rsym   (Ii  I)/(Ii) where Ii is the intensity of the ith observation and
I is the mean intensity of the reflection.
b Rwork  Fo   Fc/ Fo calculated from working data set.
c Rfree was calculated from 5% of data randomly chosen not to be included in
refinement.
d Ramachandran results were determined by MolProbity.
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energies within a range of 6.8 kcal/mol for sulfated systems in
which 4C1 and 1C4 displayed similar energies whereas 2S0 was
less favored by 6.8 kcal/mol. In the nonsulfated cases, 4C1 and
2S0 have similar energies and 1C4 is less favored by only 3.3
kcal/mol. In both cases when GlcA is substituted for IdoA, the
trisaccharides tend to become less favorable in energy (by 4.2
kcal/mol compared with 4C1 in the sulfated case and by 9.7
kcal/mol 4C1 in the nonsulfated case).
Using molecular dynamics, solution structures of the HS
heptasaccharide fragment in its free and 2OST bound forms
were generated. The initial structure of the HS bound to the
2OST was based on the x-ray crystal structure. Necessary con-
formation changes (from 4C1 to 1C4 and 2S0) were introduced to
the acceptor IdoA as well as substitution with a GlcA in a 4C1
conformation. The models were first energy-minimized in a
vacuum using the program Amber.12 (24). Next, each opti-
mized configuration was solvated in a box of water (8,113 water
molecules in 2OST-free systems and 24,121 water molecules in
2OST-bound systems). Prior to equilibration, all systems were
subjected to 1) 1-ns belly dynamics runs with fixed HS (or
HS/2OST), 2) minimization, 3) low temperature constant pres-
sure dynamics at fixed HS (or HS/2OST) to assure a reasonable
starting density, 4) minimization, 5) stepwise heating molecular
dynamics at constant volume, and 6) constant volume molecu-
lar dynamics for 1 ns. All final unconstrained trajectories were
calculated at 300 K under constant volume (25 ns, time step 1 fs)
using PMEMD (Amber.12) to accommodate long range inter-
actions (24). The protein parameters were taken from the FF12
force field (24). Charges for the sugars were obtained using
the Gaussian (25) calculations of appropriate fragments at the
B97-XD level with the higher extended 6-311g(d,p) basis
set (with the polarization continuum model with water as the
solvent) (supplemental Fig. S1).
Preparation of Oligosaccharide Substrates—Preparation of
the substrates followed essentially the same procedures
described in our previous work (16, 26). All oligosaccharides
were elongated from p-nitrophenol (PNP) glucuronide (GlcA-
PNP), which was purchased from Sigma. Briefly, GlcA-PNP
(0.20 mg/ml) was incubated with UDP-GlcNTFA (0.50 mg/ml)
or UDP-GlcNAc (0.46 mg/ml) and KfiA (N-acetyl glucosaminyl
transferase of Escherichia coli K5 strain, 0.05 mg/ml) in buffer
containing 25 mM Tris-HCl, pH 7.2, and 10 mM MnCl2 for 24 h
at room temperature. The reaction was monitored using a poly-
amine-based HPLC column. Upon the complete consumption
of UDP-GlcNTFA/GlcNAc, UDP-GlcA (0.44 mg/ml), and
PmHS2 (Pasteurella multocida heparosan synthase 2, 0.05
mg/ml) were added, and the reaction was incubated for another
24 h at room temperature. The reaction was purified using a C18
column (0.75  20 cm; Biotage), and product eluted with a
linear gradient of 0 –100% methanol in H2O and 0.1% TFA over
60 min at a flow rate of 2.0 ml/min. The trisaccharide product
was determined by exploiting the UV absorbance of the PNP
tag at 310 nm, and the identity of the product was confirmed by
electrospray ionization-MS. Further elongation to the desired
size of oligosaccharides was achieved by an additional reaction
with the incubation of UDP donors, KfiA, or PmHS2 following
the same procedure as described above.
Oligosaccharide backbones (1	2 mg) were dried and resus-
pended in 0.1 M LiOH solution (20 ml). The reaction was incu-
bated on ice for 2 h and then stopped by adjusting the pH to 7.0.
N-Sulfation of oligosaccharides was carried out by incubating
the de-NTFA oligosaccharide substrates with N-sulfotrans-
ferase and PAPS. The reaction mixture typically contained 1	2
mg of de-NTFA oligosaccharide, 500 M PAPS, 50 mM MES,
pH 7.0, and 1 mg of N-sulfotransferase in a total volume of 15
ml. The reaction mixture was incubated overnight at 37 °C.
The N-sulfated oligosaccharides were incubated overnight at
37 °C with C5-epimerase in 50 mM MES buffer, pH 7.0, contain-
ing 2 mM CaCl2. To get the IdoA2S saccharide, the oligosaccha-
rides were incubated overnight at 37 °C with C5-epimerase,
2OST, and PAPS in a buffer containing 50 mM MES, pH 7.0, and
2 mM CaCl2. For 6-O-sulfation, the reaction mixture contained
6-O-sulfotransferases (6OST-1 and 6OST-3) and PAPS. Each
of the reactions was incubated overnight at 37 °C and then puri-
fied by Q-Sepharose FF column (GE Healthcare).
Site-directed Mutagenesis—The 2OST mutants were pre-
pared using MBP-2OST plasmid as the template and a method
from the Stratagene QuikChange mutagenesis protocol. The
mutagenesis primers were synthesized by Invitrogen. The
resultant constructs were sequenced to confirm the expected
mutation (University of North Carolina at Chapel Hill Genome
Sequencing Facility). The expression of mutants was carried
out in Origami B cells (Novagen) using a protocol described
previously (18). The mutant proteins were purified by an Amy-
lose-agarose column (New England Biolabs). All mutants
described in this study, including Y94A, H106A, R184A,
R189A, and K354A, have an expression level very comparable
with that of wild type protein, as determined by SDS-PAGE
analysis.
Activity Measurement of 2OST Mutants Using Substrates 3
and 4—The procedures for the analysis of 2OST mutants were
essentially identical to those described previously (18), with the
exception of using two structurally defined oligosaccharide
substrates, compounds 3 and 4. To use compound 3 as a sub-
strate, the substrate (0.1 mg/ml) was incubated with the mutant
protein (0.1 mg/ml) and 35S-PAPS (1  106 cpm) in 25 mM MES
buffer, pH 7.0. The reaction was incubated at 37 °C for 30 min
and was terminated by heating at 100 °C for 2 min. The reaction
was then analyzed by silica-based polyamine HPLC. To use
compound 4 as a substrate, the substrate (0.1 mg/ml) was incu-
bated with the mutant protein (0.1 mg/ml) and 35S-PAPS (1 
106 cpm) in 25 mM MES buffer, pH 7.0. The reaction was incu-
bated at 37 °C for 5 min and was terminated by heating at 100 °C
for 2 min.
Mass Spectrometry Analysis—MS analysis was performed on
a Thermo LCQ-Deca. The oligosaccharides were dissolved in
H2O and injected via direct infusion (40 l/min) into the instru-
ment. The experiments were performed utilizing a negative
ionization mode with a spray voltage of 3 kV and a capillary
temperature of 160 °C. The MS data were acquired and pro-
cessed using Xcalibur 1.3 software.
NMR Analysis of Heptasaccharide Substrate—The structure
of oligosaccharides constructs and intermediates were ana-
lyzed by NMR experiments, including one-dimensional (1H
and 13C) and two-dimensional (1H-1H COSY, TOCSY, and
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1H-13C HSQC) NMR. NMR experiments were performed at
298 K with a Varian Inova 500 MHz spectrometer equipped
with 5-mm triple resonance XYZ or broadband PFG probe and
processed by VnmrJ 2.2D software. Samples (2 mg) were each
dissolved in 0.5 ml of D2O (99.994%; Sigma) and lyophilized
three times to remove the exchangeable protons. The samples
were redissolved in 0.5 ml of D2O and transferred to NMR
microtubes (OD 5 mm; Norrell). One-dimensional 1H NMR
experiments were performed with 256 scans and an acquisition
time of 768 ms. One-dimensional 13C NMR experiments were
performed with 40,000 scans, 1.0-s relaxation delay, and an
acquisition time of 1000 ms. Two-dimensional (1H-1H COSY,
TOCSY, and 1H-13C HSQC) spectra were recorded with car-
bon decoupling, 1.5-s relaxation delay, during 204-ms acquisi-
tion time with 500 increments for 48 scans.
Taking advantage of one-dimensional and two-dimensional
NMR experiments, we were able to assign anomeric protons
and chemical shifts of saccharide E with GlcA or IdoA in the
heptasaccharides. At low field region of compound 11 spec-
trum, the anomeric protons are D1 (5.63 ppm), F1 (5.60 ppm),
B1 (5.37 ppm), and G1 (5.28 ppm). Comparing the spectra of
compound 11 and 12, we found another new signal 5.34 ppm
was represented only in compound 12. However, the GlcA pro-
ton chemical shifts at saccharide E of compound 11 are 4.52,
3.84, 3.83, 3.78, and 3.36 ppm; and as expected, another series of
IdoA proton signals, 5.34, 4.94, 4.09, 4.04, 3.99 ppm, showed up
for compound 12. Comparing the HSQC spectra of compound
11 and 12 also confirmed the presence of IdoA residue in com-
pound 12. In the 1H NMR spectrum of compound 12, the pro-
ton peaks of IdoA also showed as smaller coupling constants or
broad shape, not typically larger axial-axial coupling constants
in GlcA, supporting the existence of IdoA and fast conforma-
tional equilibrium among chair (4C1 and 1C4) and skew-boat
(2S0) conformers. In addition, based on the integration value of
the proton spectra, the epimerization product in compound 12
contained approximately 40% IdoA and 60% GlcA, which was
also in agreement with the HPLC analysis.
RESULTS
Crystal Structure of 2OST with Bound Heptasaccharide—To
crystalize 2OST, a MBP fusion with 2OST from chicken
(92% identity to human) was utilized (18, 27). The structure of
the ternary complex of MBP-2OSTPAPheptasaccharide was
solved at 3.45 Å resolution (Table 1 and Fig. 1, B and C). The
crystal structure contains two symmetrical MBP-2OST trimers
in the asymmetric unit. These trimers are similar to those of the
MBP-2OSTPAP binary complex and are believed to represent
the functional oligomeric state of the enzyme (18). Intermolec-
ular interactions within the trimer are formed by extension of
the C-terminal tail of one monomer across the active site of a
neighboring monomer, forming an antiparallel -strand on the
edge of the central parallel -sheet of the neighboring mono-
mer (Fig. 1, B and C) (18). This arrangement results in 24%
buried surface area for each monomer. In the first trimer
(monomers A–C), there is no electron density for the MBP
portion of monomer A, and the MBP portion of monomer B is
substantially disordered. As well, there is no interpretable elec-
tron density for the heptasaccharide binding to monomer C. In
the second trimer (monomers D–F), all monomers contain
heptasaccharide bound, but the MBP portion of monomer F
shows substantial disorder. All MBP molecules in the asymmet-
ric unit are found in different orientations relative to the fused
2OST, suggesting flexibility in the linker between MBP and
2OST. Such flexibility in the linker region was not observed in
the MBP-2OSTPAP binary complex. Attempts to shorten the
linker to decrease flexibility failed to improve crystal quality.
FIGURE 1. Crystal structure of the 2OST trimer. A, chemical structure of the heptasaccharide substrate used in the ternary complex. B, crystal structure of the
2OST trimer with each monomer (colored dark blue, slate, and light blue) bound to a molecule of PAP (pink) and heptasaccharide substrate (green) (monomers
D, E, and F). The C terminus of each subunit (circled in magenta) extends into the active site of the neighboring molecule. C, B rotated 90° with respect to the
horizontal axis in the plane of the paper.
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The substrate preparation is a mixture of two heptasaccha-
rides: one contains the IdoA at position E (structure shown in
Fig. 1A) and the other a GlcA residue at position E. HPLC anal-
ysis revealed that the ratio of IdoA to GlcA at position E is
1.0:1.2 (Fig. 2A). Because 2OST preferentially sulfates the IdoA-
containing heptasaccharide (as demonstrated in Fig. 2, B–F),
we used the epimeric mixture for this study because of the dif-
ficulty in purifying large quantities of the specific IdoA epimer
for crystallography.
The heptasaccharide substrates are bound in a surface cleft
on the outside of each monomer at a trimer interface and are
separated by 	50 Å (Figs. 1, B and C, and 3, A–D). The cleft is
formed by positively charged residues in the active site and
C-terminal residues from the neighboring monomer. The ori-
entation of the heptasaccharides in the active sites was deter-
mined by the clear electron density for the N-sulfo groups and
the number or residues that could fit into the density from the
acceptor saccharide (Fig. 3A). The heptasaccharide binds with
the reducing end at the top of the trimer and the nonreducing
end nearest the N-terminal side of the trimer. All five of the
heptasaccharide molecules in the crystal structure bind in a
similar manner with the greatest uniformity at the acceptor
saccharide (saccharide E) and the adjacent GlcNS saccharides
(Fig. 3B). The greatest differences exist at the ends of the
heptasaccharide away from the acceptor site.
To determine the identity and conformation of the acceptor
saccharide crystallographic refinement was carried out with
this sugar modeled as GlcA in the 4C1 conformation and as
IdoA in 4C1, 1C4, and 2S0 conformations. Based on the best fit to
the electron density, the acceptor saccharide was modeled as an
IdoA in the 4C1 conformation (Fig. 4, A–D). Because the reso-
lution (3.45 Å) does not allow for unambiguous identification of
the sugar or ring conformation at the acceptor site, molecular
dynamic simulations were carried out on all four sugar confor-
mations for 25 ns. The conformations 1C4 and 2S0 have been
previously reported as preferred conformations for HS struc-
tures (28, 29). Among the three possible conformations for
IdoA, the 4C1 conformation displayed the strongest binding
energy (
E) (Table 2), supporting the crystallographic assign-
ment of saccharide E as an IdoA in the 4C1 conformation while
binding 2OST. The GlcA showed weaker interaction energy
than the IdoA in the 4C1 conformation(
E) (Table 2), consis-
tent with experimental results demonstrating a 5-fold higher
affinity for IdoA-containing versus GlcA-containing substrates
(30). However, given the relatively small range for the interac-
tion energies of the IdoA conformations, coupled with the
inherent errors in the calculation of interaction energy for this
system, it is difficult to rule out any of the three IdoA confor-
mations. The 4C1 conformation, nevertheless, provides the best
fit to the electron density. The decision to rule out a GlcA res-
idue is also based on IdoA being the preferred substrate by a
10:1 ratio when a mixture of this heptasaccharide substrate is
provided to 2OST (Fig. 2, B–F). Crystallographic refinement of
the acceptor as an IdoA in the 4C1 conformation also positions
the acceptor 2-OH 4.9 Å from the leaving group oxygen of PAP,
consistent with a catalytically relevant binding position (Fig.
3A).
FIGURE 2. Anion-exchange HPLC chromatograms of heptasaccharide modified by 2OST. A, starting mixture of heptasaccharide substrate with no 2OST
present. B–F, results after mixing heptasaccharide substrates in the presence of 2OST and PAPS at different concentrations (2.5, 12.5, 50, 100, and 400 M,
respectively). The mixture of heptasaccharide substrate yielded a very similar ratio of GlcA2S-containing product (1) and IdoA2S-containing product (2) under
different concentrations of substrate, suggesting that 2OST preferentially sulfates IdoA-containing substrate in a wide range of substrate concentrations. The
ratio of the areas under peak 2 and peak 1 for each analysis is shown.
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Upon binding substrate, a number of residues have become
ordered or are found in a different conformation due to inter-
actions with the substrate. Most notably, the loop containing
residues 185–196 shifts more than 2.0 Å closing down on the
heptasaccharide compared with the substrate-free binary
structure (Fig. 3C).
A number of specific interactions exist between the protein
and heptasaccharide (Fig. 3D). The reducing end GlcA (saccha-
ride G) is positioned between Asn-112 and Arg-190. Arg-190
has become ordered upon substrate binding and along with
Tyr-173 is in position to form hydrogen bonds with the carbox-
ylate group of this saccharide. For saccharide F (GlcNS) the
N-sulfate is positioned within hydrogen bonding distance of the
backbone amide of Arg-190 as well as the side chain from Arg-
189. A number of putative interactions exist with the acceptor
IdoA (saccharide E). Residues Arg-184, Arg-189, and Arg-288
are in position to interact with the carboxylate group of the
acceptor IdoA residue. Residue His-142, the proposed catalytic
base, has assumed a single conformation within hydrogen
bonding distance to the acceptor 2-OH. This differs from the
binary structure where His-142 is observed in multiple confor-
mations (18). The N-sulfate of saccharide D lies within hydro-
gen bonding distance to Arg-80. Amino acid residues from the
C-terminal tail of the neighboring monomer also interact with
this GlcNS because Glu-349(B) is within hydrogen bonding dis-
tance to the 6-OH and Lys-350(B) is near the N-sulfate and the
3-OH. Tyr-352(B) from the C-terminal tail assumes a different
orientation from that of the binary structure and is located
within hydrogen bonding distance to the carboxylate group of
saccharide C (GlcA). In addition, Glu-349(B) may potentially
interact with this sugar as it is near the 2-OH group. Neither
saccharide B (GlcNAc) nor saccharide A (GlcA) appears to
form specific hydrogen bonding interactions with the protein;
however, in the ternary complex the side chain of Lys-354
becomes ordered and stacks with saccharide A. The lack of
specific interactions with saccharides A and B is consistent with
their increased disorder compared with saccharides C–F (Fig.
3, A and B).
Substrate Specificity of 2OST—To eliminate the confounding
effects from structurally heterogeneous polysaccharide sub-
strates, such as completely de-O-sulfated N-sulfated heparin or
N-sulfoheparosan (18), we investigated the substrate specificity
of 2OST using a series of structurally defined oligosaccharides.
A total of 14 compounds with different lengths and sulfation
content was synthesized using the chemoenzymatic synthesis
approach (Tables 3 and 4) (16, 31). The synthesis of IdoA-con-
taining substrates is somewhat limited by the substrate speci-
ficity of C5-epimerase (32, 33); therefore, only a few selective
IdoA-containing substrates were prepared. Because 2OST is
capable of sulfating either IdoA or GlcA, the majority of the
study focused on substrates containing GlcA acceptor sites
avoiding the C5-epimerase step. The oligosaccharide substrates
were carefully analyzed by using HPLC and MS to determine
the purity (Fig. 5 and 6) and extent of sulfation (Table 3). The
results from this study indicate that a pentasaccharide is the
minimum size required for sulfation by 2OST based on its abil-
ity to sulfate the pentasaccharide compound 2 but not the tet-
rasaccharide compound 1. Within the required pentasaccha-
FIGURE 3. Heptasaccharide binding. A, electron density from a simulated
annealing omit Fo  Fc map of the heptasaccharide contoured at 2.5 (from
monomer A). The PAP is shown in pink with the distance between the leaving
group oxygen of the PAP and the acceptor hydroxyl 2-OH of the IdoA (sac-
charide E) displayed in a red dashed line (4.9 Å). B, superposition of the sub-
strates from molecules B, D, E, and F (semitransparent green) into the active
site of monomer A (substrate solid green). As the distance increases from the
acceptor IdoA there is more variation in conformation. C, binding of the hep-
tasaccharide resulting in a 2 Å movement of the loop containing residues
Arg-184 through Lys-196 toward the hepatsaccahride. Residues Arg-184 and
Arg-190, which are disordered in the substrate-free binary structure, become
ordered in the bound ternary structure. D, residues involved in putative hep-
tasaccharide-substrate interactions from monomer A shown in light blue. The
residues from the C-terminal tail of neighboring monomer B are shown in
dark blue. The magenta asterisk denotes the acceptor 2-OH position. Putative
hydrogen bonds are displayed in black dashed lines.
FIGURE 4. Refinement of different conformations of the acceptor saccha-
ride. A, refinement of saccharide E as IdoA in the 4C1 conformation (green).
B–D, refinement of saccharide E as either GlcA in the 4C1 conformation, IdoA
2S0, or IdoA
1C4 ,respectively (yellow) superimposed with the IdoA
4C1 struc-
ture (green). The simulated annealing omit Fo  Fc map contoured at 4.0 is
displayed in black. Positive Fo  Fc density from each respective refinement is
shown in green (3.0), and negative density (3.0) is shown in red. In B the
black dashed line represents a salt bridge (2.9 Å) between the IdoA and Arg-
189. For GlcA this distance is 4.0 Å (red dashed line) and thus likely does not
form a salt bridge.
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ride 2OST recognizes a trisaccharide motif with the structure of
-GlcNS-GlcA-GlcNS- or -GlcNS-IdoA-GlcNS-. The acceptor
IdoA or GlcA residue must be flanked by two N-sulfoglucos-
amine residues. Replacing one of the two flanking GlcNS resi-
dues with either GlcNAc (as the case for compounds 6 and 7) or
GlcNH2 (as the case for compound 5) resulted in the loss of
2OST modification. 6-O-Sulfation on the flanking GlcNS resi-
dues of the acceptor site abolishes the reactivity to 2OST mod-
ification as demonstrated for the compounds 8, 9, and 10. The
presence of an IdoA2S residue on the reducing end of the tri-
saccharide domain has no effect on the reactivity to 2OST mod-
ification, as observed for compounds 13 and 14.
Site-directed Mutagenesis—The contribution of specific
amino acid residues in sulfation preference of IdoA versus GlcA
was investigated using site-directed mutants with two hexasa-
ccharide substrates, compounds 3 (GlcA) and 4 (IdoA). Based
on the ternary complex crystal structure we generated five
2OST mutants Y94A, H106A, R184A, R189A, and K354A for
this analysis. Our previous studies using polysaccharide sub-
strates demonstrated that mutants Y94A and H106A prefer
IdoA-containing substrates, whereas R189A prefers a GlcA-
containing substrate (18, 34). Arg-184 and Lys-354, which were
not predicted from the binary structure, were chosen for
mutagenesis because the ternary structure revealed interac-
tions between these residues and the heptasaccharide. The
mutant proteins were incubated with compounds 3 and 4 in the
presence of 35S-labeled PAPS, and the reaction mixtures were
analyzed by anion-exchange HPLC to identify formation of
TABLE 2
Molecular dynamics interaction energies of HS with 2OST
Only the five saccharides (C-G)’ that are required for activity and are well ordered in the crystal structure were used in the energy calculation of the heptasaccharide substrate
with different conformations at position E (the last 20 ns of the 25-ns simulations were used for analysis).
Acceptor saccharide E
and conformation
Total interaction energy of
HS with 2OST in presence of water
Total interaction energy






1C4, IdoA 1847.8144.0 974.8100.1 873.0 2.910.19
4C1, IdoA 1893.0135.6 966.8105.5 926.2 2.840.18
2S0, IdoA 1857.2143.2 966.3110.1 890.9 3.100.24
4C1, GlcA 1859.7145.6 978.0111.3 881.7 3.100.30
4C1, IdoA 2OST(R189A) 1836.3150.2 966.8105.5 869.5 3.310.36
TABLE 3







1 Tetrasaccharide GlcNS-GlcA-GlcNS-GlcA-PNP 0.47  0.08
2 Pentasaccharide GlcA-GlcNS-GlcA-GlcNS-GlcA-PNP 4.17  0.03
3 Hexasaccharide GlcNAc-GlcA-GlcNS-GlcA-GlcNS-GlcA-PNP 7.20  0.38
4 Hexasaccharide GlcNAc-GlcA-GlcNS-IdoA-GlcNS-GlcA-PNP 10.71  0.63
5 Hexasaccharide GlcNAc-GlcA-GlcNH2-GlcA-GlcNS-GlcA-PNP 0.08
6 Hexasaccharide GlcNAc-GlcA-GlcNHAc-GlcA-GlcNS-GlcA-PNP 0.08
7 Hexasaccharide GlcNAc-GlcA-GlcNS-GlcA-GlcNHAc-GlcA-PNP 0.08
8 Hexasaccharide GlcNAc6S-GlcA-GlcNS6S-GlcA-GlcNS6S-GlcA-PNP 0.08
9 Hexasaccharide GlcNAc-GlcA-GlcNS-GlcA-GlcNS6S-GlcA-PNP 0.08
10 Hexasaccharide GlcNAc-GlcA-GlcNS-GlcA-GlcNAc6S-GlcA-PNP 0.08
13 Octasaccharide GlcNAc-GlcA-GlcNS-GlcA-GlcNS-IdoA2S-GlcNS-GlcA-PNP 8.22  0.40
14 Octasaccharide GlcNAc-GlcA-GlcNS-IdoA-GlcNS-IdoA2S-GlcNS-GlcA-PNP 14.08  0.68
a The boxed trisaccharide domain, -GlcNS-GlcA-GlcNS- or–GlcNS-IdoA-GlcNS-, is designated the recognition site by 2OST, where PNP represents the p-nitrophenol
group.
b The susceptibility of the oligosaccharide substrates to 2OST modification was determined by the analysis using anion exchange-HPLC. The presented value is the average
of two determinations  range.
TABLE 4
Summary of the HPLC and MS analysis of oligosaccharide substrates




1 GlcNS-GlcA-GlcNS-GlcA-PNP 98 1.5 973.6  0.0 (973.8)
2 GlcA-GlcNS-GlcA-GlcNS-GlcA-PNP 97 2.0 1149.8  0.4 (1149.9)
3 GlcNAc-GlcA-GlcNS-GlcA-GlcNS-GlcA-PNP 98 12.5 1353.4  0.2 (1353.1)
4 GlcNAc-GlcA-GlcNS-IdoA-GlcNS-GlcA-PNP 96 0.7 1353.0  0.4 (1353.1)
5 GlcNAc-GlcA-GlcNH2-GlcA-GlcNS-GlcA-PNP 99 2.5 1272.9  0.2 (1273.0)
6 GlcNAc-GlcA-GlcNAc-GlcA-GlcNS-GlcA-PNP 99 8.5 1315.0  0.4 (1315.1)
7 GlcNAc-GlcA-GlcNS-GlcA-GlcNAc-GlcA-PNP 99 10 1315.0  0.5 (1315.1)
8 GlcNAc6S-GlcA-GlcNS6S-GlcA-GlcNS6S-GlcA-PNP 96 0.3 1593.1  0.3 (1593.3)
9 GlcNAc-GlcA-GlcNS-GlcA-GlcNS6S-GlcA-PNP 97 5.0 1433.2  0.3 (1433.2)
10 GlcNAc-GlcA-GlcNS-GlcA-GlcNAc6S-GlcA-PNP 98 6.0 1395.3  0.6 (1395.2)
11 GlcA-GlcNAc-GlcA-GlcNS-GlcA-GlcNS-GlcA-PNP 98 25 1529.4  0.6 (1529.3)
12a GlcA-GlcNAc-GlcA-GlcNS-GlcA-GlcNS-GlcA-PNP and
GlcA-GlcNAc-GlcA-GlcNS-IdoA-GlcNS-GlcA-PNP
52 and 48 60 1529.4  0.9 (1529.3)
13 GlcNAc-GlcA-GlcNS-GlcA-GlcNS-IdoA2S-GlcNS-GlcA-PNP 99 5.0 1850.0  0.1 (1850.5)
14 GlcNAc-GlcA-GlcNS-IdoA-GlcNS-IdoA2S-GlcNS-GlcA-PNP 98 0.5 1850.4  0.5 (1850.5)
a Compound 12 was used to obtain the co-crystal structure with 2-OST.
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the 35S-labeled hexasaccharide product (Fig. 7). It should be
noted that the experiment was intended to compare the reac-
tivity of different 2OST mutants toward GlcA-containing and
IdoA-containing substrates. Here, only 35S-labeled products
were detected. Because the substrates (compounds 3 and 4)
have no radioactive tag, they were invisible in this analysis. It is
likely that only a small portion of compounds 3 and 4 partici-
pated in the reaction. Thus, the analysis was not used to assess
the completion of the 2-O-sulfation for each substrate.
Measuring the relative reactivity of the mutants toward com-
pounds 3 and 4 permitted us to assess the contribution of the
amino acid residues to recognize a GlcA-containing substrate
versus an IdoA-containing substrate (Table 5). Indeed, R189A
remains reactive to compound 3 (GlcA) but loses its reactivity
to compound 4 (IdoA) (Fig. 7, B and E, and Table 5). This result
is consistent with our previous findings using polysaccharide
substrates (18). Mutant K354A exhibits comparable reactivity
of the wild type protein to compounds 3 and 4, suggesting that
Lys-354 is not important for substrate recognition or enzymatic
activity (Fig. 7, C and F, and Table 5). However, 2OST R184A
loses reactivity toward both substrates, suggesting that Arg-184
is crucial for activity (Table 5). Mutants 2OST Y94A and
H106A display a modest reduction in reactivity toward both
compounds 3 and 4 (Table 5). The data demonstrate that
Tyr-94 and His-106 residues are not directly involved in distin-
guishing between GlcA and IdoA within the context of com-
pounds 3 and 4 but may be involved in recognizing alternative
sequence patterns present in the previously utilized heteroge-
neous polysaccharide substrates. Indeed, no direct interactions
between Tyr-94 and His-106 with the hexasaccharide substrate
are observed in the ternary crystal structure.
DISCUSSION
The biosynthesis of HS involves the actions of multiple sul-
fotransferases and an epimerase. 2OST plays an essential role in
assembling HS with desired structures for a multitude of bio-
logical functions. Although HS biosynthesis is not a template-
driven process, the overall structure of HS from a single cell
type remains largely unchanged for generations (35). Deter-
mining the substrate specificity via crystallography and struc-
turally defined oligosaccharide substrates helps define the reg-
ulatory role of 2OST in HS biosynthesis.
The results from this study reveal several central conclu-
sions. First, the acceptor IdoA residue in the heptasaccharide
FIGURE 5. Anion-exchange HPLC chromatograms of synthetic oligosaccharide substrates. Each synthesized oligosaccharide substrate was analyzed by
anion-exchange HPLC to determine the purity of the compound.
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appears to be in the 4C1 conformation. This conformation is
distinct from previous data that suggests IdoA assumes either
the 1C4 or 2S0 conformation within the context of HS (36).
Because GlcA is only observed in the 4C1 conformation, one
possible advantage for the IdoA being in the 4C1 conformation
is that the active site of 2OST needs only to bind one sugar
conformation to be able to accommodate and sulfate both IdoA
and GlcA. Residue Arg-189 may function to stabilize the 4C1
conformation for the IdoA substrate as the R189A mutant loses
activity for IdoA containing substrates while still maintaining
significant activity for GlcA-containing substrates. This notion
is supported by the fact that in the crystal structure Arg-189
forms a putative salt bridge with the carboxylate of the IdoA,
but based on the crystallographic refinement, would not be in
position to interact with the carboxylate of GlcA (Fig. 4B). In
addition, the molecular dynamics studies show a decrease
in the interaction energy (
E) between the IdoA-containing
4C1 substrate and the R189A mutant (Table 2), potentially
destabilizing binding by the mutant compared with the wild
type protein. In the present study, a heptasaccharide substrate
was used for the crystal study. Because the heptasaccharide only
represents a small portion of a polysaccharide substrate, our
model does not rule out that additional interaction may exist
between the enzyme and substrate outside the heptasaccharide.
Second, 2OST requires at least a pentasaccharide for display-
ing its full activity. This is consistent with the crystal structure
which suggests saccharides C–G of the heptasaccharide form
all of the observed specific interactions with the protein. The
tetrasaccharide domain D–G represents the structure of com-
pound 1, whereas the pentasaccharide domain C–G represents
the structure of compound 2. Removal of the nonreducing end
GlcA from compound 2 would result in potentially two fewer
hydrogen bonds with the substrate at residue Glu-349(B) and
Tyr-352(B) (Fig. 3D), supporting the dependence of this
saccharide.
Third, 2OST has evolved in a way that enables it to discrim-
inate based on sulfation patterns, ensuring that a programmed
sulfation sequence is followed. The substrate specificity study
demonstrates that a 2OST acceptor site must be flanked by two
GlcNS residues, consistent with the fact that the N-sulfo groups
interact with numerous points of 2OST. In the crystal structure,
both flanking GlcNS saccharides show strong electron density
for their 2S-sulfates and are very well ordered (Fig. 3A). The
N-sulfo group from saccharide F(GlcNS) on the reducing side
FIGURE 6. MS spectra of synthetic oligosaccharide substrates. Each synthesized oligosaccharide substrate was analyzed by electrospray ionization-MS to
determine the molecular mass.
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forms putative hydrogen bonds with the backbone amide from
Arg-190 and possibly side chain interactions with Arg-189.
Arg-189 also appears to interact with the carboxylate on the
acceptor IdoA (saccharide E). Although R189A loses substan-
tial activity for compound 4 (IdoA), it maintains substantial
activity for compound 3 (GlcA), suggesting that its interaction
with the N-sulfo group is not the predominant role. The N-sulfo
groups from saccharide D (GlcNS) on the nonreducing side are
within hydrogen bonding distance to Arg-80 and Lys-350(B)
(Fig. 3D). The 2OST R80A mutant was previously shown to
have 2% of wild type activity, whereas 2OST K350A displayed
25%, suggesting that these interactions are important for sub-
strate binding (18). Taken together, these observations imply
that N-sulfation is a prerequisite for 2-O-sulfation.
Finally, unlike the requirement for N-sulfation near the
acceptor site, the 6-O-sulfation has precisely the opposite effect
on 2OST activity. The interactions between proteins and HS
generally involve charge-charge interactions (37); namely, an
increase in the binding affinity would be expected when the
total number of sulfo groups is increased. On the contrary, 6-O-
sulfation on the reducing side of the acceptor saccharide (com-
pound 9) prevents modification by 2OST. Based on the crystal
structure, 6-O-sulfation on saccharide F, on the reducing side of
the acceptor saccharide, would create steric clashes with Pro-82
and/or Tyr-173, interfering with its ability to bind within the
substrate binding cleft (Fig. 8A). 6-O-Sulfation is also likely
selected against on the nonreducing adjacent glucosamine due
to charge repulsion with Glu-349(B) from the neighboring
monomer (Fig. 8B). These results suggest that 2-O-sulfation
must occur prior to 6-O-sulfation to create a domain contain-
ing -IdoA2S-GlcNS6S-, a common disaccharide repeating unit
FIGURE 7. Anion-exchange HPLC chromatograms of oligosaccharide substrates modified by 2OST wild type and mutant proteins. Two oligosaccharide
substrates, compound 3 and 4, were incubated with 2OST proteins in the presence of 35S-labeled PAPS followed by anion-exchange HPLC analysis. A–C
represent chromatograms of the GlcA-containing substrate incubated with wild type 2OST (red tracing), 2OST R189A, and 2OST R354A, respectively. D–F
represent chromatograms of the IdoA-containing substrate incubated with wild type 2OST, 2OST R189A, and 2OST R354A, respectively. Control reactions have
no enzyme (blue tracing in both A and D). For the left column (A–C), the 35S-labeled peak eluted at 32–33 min contains the desired product. The 35S-labeled peak
eluted at 38 min is PAPS. * indicates an unidentified peak. For the right column (D–F), the35S-labeled peak eluted at 35–36 min is the desired product.
TABLE 5




Reactivity to compound 3
(GlcA-containing substrate)
Reactivity to compound 4
(IdoA-containing substrate)
% %
2OST WT 100 100
2OST Y94A 23.0 35.7
2OST H106A 16.8 27.7
2OST R184A 10.1 8.3
2OST R189A 81.7 2.4
2OST K354A 82.0 101.2
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found in HS (38). Our conclusion is consistent with the current
sequential model for the HS biosynthetic pathway with N-sul-
fation occurring first, followed by C5-epimerization/2-O-sulfa-
tion, 6-O-sulfation, and 3-O-sulfation, respectively.
Sulfation patterns of HS determine the binding specificity to
protein targets. The crystal structure of HS oligosaccharide
bound to 2OST provides an example of the mechanism used by
a protein to recognize a specific sulfation pattern. Decoding the
recognition mechanism between sulfated saccharides and pro-
teins will advance our understanding of the fundamental func-
tions of HS. Furthermore, understanding the substrate recog-
nition by 2OST and other HS biosynthetic enzymes will likely
improve the capability of the chemoenzymatic synthesis tech-
nology to prepare targeted heparin-based therapeutics.
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